Related Experiment Videos

Human erythroleukemia cells adhere to fibronectin: evidence for a Mr 190,000-receptor protein

Blood
|February 1, 1987
PubMed

Insights

Human erythroleukemia cells (K562) rapidly adhere to fibronectin via a specific receptor. This adhesion and cell spreading are mediated by the actin cytoskeleton and are inhibited by the RGDS peptide.

Area of Science:

  • Cell biology
  • Biochemistry
  • Molecular biology

Background:

  • Fibronectin (Fn) is a crucial extracellular matrix protein involved in cell adhesion, migration, and differentiation.
  • K562 erythroleukemia cells provide a model system to study cell adhesion mechanisms.

Purpose of the Study:

  • To identify and characterize the fibronectin receptor on K562 cells.
  • To investigate the role of the cytoskeleton in fibronectin-mediated cell adhesion and spreading.

Main Methods:

  • Cell adhesion assays using fibronectin-coated substrata.
  • Inhibition studies with RGDS peptide, cytochalasin B, and microtubule-disrupting drugs.
  • Overlay assays with radiolabeled fibronectin and cell extracts.
  • Affinity chromatography using Fn-heptapeptide-Sepharose.

Main Results:

  • K562 cells exhibit rapid adhesion and spreading on fibronectin, dependent on the microfilament system.
  • A 190,000 Mr fibronectin-binding protein was identified in K562 cells, which is downregulated upon hemin-induced differentiation.
  • The RGDS peptide inhibited fibronectin binding, and a Mr 190,000/185,000 membrane glycoprotein was isolated that binds to fibronectin.

Conclusions:

  • A Mr 190,000 polypeptide functions as the primary fibronectin receptor in K562 cells.
  • Cell spreading involves active participation of the actin cytoskeleton.
  • Fibronectin receptor expression is regulated during erythroid differentiation.

Related Concept Videos